Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
U.S. stocks rose, Nasdaq gained ~400 points. Moderna jumped 9.1% on strong Q3 results and higher FY26 guidance; other stocks rallied on results and deals.
Filings · News reference
Clean Energy Fuels Form4 Filing Shows CEO Barclay Corbus Buys 25,000 Shares At $1.62 Average Price
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Transcript: Clean Energy Fuels Q2 2026 Earnings Conference Call
Clean Energy Fuels (NASDAQ:CLNE) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
8-K filing — Clean Energy Fuels Corp. (CLNE)
Filed: 2026-10-06 AccNo: 0001104659-26-113910 Size: 501 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Clean Energy Fuels Appoints JJ Armstrong As CFO, Effective Immediately
Armstrong has been with Clean Energy since 2014 when he joined as Director of SEC Reporting and Divisional Controller and has since advanced to Vice President and Corporate Controller. During his tenure, he has played a
Clean Energy Fuels Sells $30.7M Of Federal Tax Credits From Seven Of Its Renewable Natural Gas Production Facilities
The sale marks Clean Energy's fourth successful transaction monetizing credits from its RNG projects. The largest credit in the transaction is the $26 million investment tax credit (ITC) tied to South Fork Dairy,
Why Clean Energy Fuels Stock Slumped This Week
Clean Energy Fuels (CLNE) stock fell nearly 12% this week after Raymond James analyst Pavel Molchanov cut his price target from $4 to $2.50 per share, citing the company's adjusted net loss in Q2 results. Despite the significant cut, Molchanov maintained a strong buy rating, expressing optimism about natural gas fuel growth prospects and the company's diversification efforts.